CLVT Stock Recent News

I rate Clarivate a buy, as 1Q25 marks a potential turning point with positive organic growth driven by stronger renewals and a healthier recurring revenue mix. CLVT's recurring revenue now makes up 83% of total sales, with organic recurring revenue growing by 0.6% y/y, indicating improved fundamentals. The IP segment shows promise, with 1.3% y/y organic growth, driven by stronger patent renewals and new AI tools like Derwent's AI-powered search feature.

DELRAY BEACH, Fla., May 2, 2025 /PRNewswire/ -- The global Life Science Analytics Market , valued at US$35.69 billion in 2024, is forecasted to grow at a robust CAGR of 11.4%, reaching US$40.03 billion in 2025 and an impressive US$68.81 billion by 2030. The standardization of diverse datasets from sources such as clinical trials, electronic health records (EHRs), genomics, and real-world evidence is essential for the efficient exchange of information across various platforms and geographical regions. This standardization enhances multi-site clinical trials and cross-border research collaborations. Additionally, emerging technologies like artificial intelligence (AI), quantum computing, and cognitive computing play a vital role in transforming large volumes of raw data into actionable insights. These technologies help simplify reports and create interactive dashboards. Furthermore, the increasing adoption of analytics in pre-clinical trials, drug discovery, and clinical trials, particul

Clarivate Plc (NYSE:CLVT ) Q1 2025 Earnings Conference Call April 29, 2025 9:00 AM ET Company Participants Mark Donohue - Vice President, Investor Relations Matti Shem Tov - Chief Executive Officer Jonathan Collins - Chief Financial Officer Conference Call Participants Greg Parrish - Morgan Stanley David Paige - RBC Capital Markets Shlomo Rosenbaum - Stifel George Tong - Goldman Sachs Surinder Thind - Jefferies Operator Thank you for joining ladies and gentlemen. My name is Karen, I'll be your conference operator.

The headline numbers for Clarivate (CLVT) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Clarivate PLC (CLVT) came out with quarterly earnings of $0.14 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.14 per share a year ago.

— Accelerated recurring organic revenue growth — — Reaffirmed 2025 Outlook — — Repurchased $50 million ordinary shares — LONDON , April 29, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the first quarter ended March 31, 2025. Total revenues for the first quarter of 2025 was $593.7 million, compared to total revenues of $621.2 million for the first quarter of 2024.

New solution provides integrated provider intelligence and real-world data to optimize targeting, strategic planning and patient access across commercial organizations LONDON , April 23, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today announced the launch of DRG Commercial Analytics 360—a solution designed to empower medtech companies with advanced insights to drive commercial performance. As the demand for precise, analytics-driven strategies grows, medtech companies require deeper visibility into customer activity, affiliations, practice behavior and caseloads.

Enhancing research efficiency and accuracy with newly integrated features  LONDON , April 23, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, today released EndNote 2025, a comprehensive reference management solution that streamlines the research and writing process. Its new features include AI support, enhanced referencing tools, and journal matching capabilities, designed to save researchers time and improve accuracy.

Clarivate (CLVT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

LONDON , April 2, 2025 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the first quarter 2025 before the market opens on Tuesday, April 29, 2025. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com.